Efficacy of Probiotic Saccharomyces boulardii as an Adjuvant Therapy in Acute Childhood Diarrhoea

Authors

  • Dillip Kumar Dash IMS and SUM Hospital, Bhubaneswar
  • Mrutunjaya Dash IMS and SUM Hospital, Bhubaneswar
  • M.D. Mohanty IMS and SUM Hospital, Bhubaneswar
  • Naresh Acharya IMS and SUM Hospital, Bhubaneswar

DOI:

https://doi.org/10.3126/jnps.v36i3.15539

Keywords:

Childhood diarrhoea, Saccharomyces boulardii, therapy.

Abstract

Introduction: Administration of S. boulardii in addition to rehydration therapy in diarrhea found to be beneficial in many aspects owing to a variety of causes and importantly it is was not associated with any adverse effects.

Material and Methods: We conducted a prospective study of children suffering from acute diarrhoea, at a private tertiary care hospital. Children were divided into 2 groups randomly as per odd(Group 1 ) and even (Group 2) bed allotted in indoor at the time of admission: Group 1 included children on oral rehydration therapy (ORT) + Zinc + Saccharomyces boulardii (Probiotic 5 billion CFU twice daily) and Group 2 comprised of children on ORT+ Zinc. Our objective was to systematically review data on the effect of S. boulardii on acute childhood diarrhoea.

Results: Out of a total of 126 children less than 2 years, 2-6 years and 6-14 years were 72 (57.14%), 42(33.33%) and 12(09.52%) respectively. The duration of diarrhoea in Group 1 was 26.31 hours and Group 2 was 47.81 hours (p<0.01). The frequency of diarrhoea showed improvement within 24 and 72 hours in Group 1 and Group 2 respectively (p<0.01).Similarly, the mean duration of hospital stay was 2.68 days in Group 1 and 4.8 days in Group 2.The treatment cost was INR 850 and INR 1650 while social cost was INR 1250 and 2600 in Group 1 and 2 respectively.

Conclusion:This study shows that S. boulardii reduced the duration, frequency and hospital stay of diarrhoea thereby reducing the treatment and social costs.

J Nepal Paediatr Soc 2016;36(3):250-255

Downloads

Download data is not yet available.
Abstract
1600
PDF
1192

Author Biographies

Dillip Kumar Dash, IMS and SUM Hospital, Bhubaneswar

Professor, Department of pediatrics

Mrutunjaya Dash, IMS and SUM Hospital, Bhubaneswar

Professor, Department of Paediatrics

M.D. Mohanty, IMS and SUM Hospital, Bhubaneswar

Professor, Department of Paediatrics

Naresh Acharya, IMS and SUM Hospital, Bhubaneswar

Senior Resident, Department of Paediatrics

Downloads

Published

2017-04-16

How to Cite

Dash, D. K., Dash, M., Mohanty, M., & Acharya, N. (2017). Efficacy of Probiotic Saccharomyces boulardii as an Adjuvant Therapy in Acute Childhood Diarrhoea. Journal of Nepal Paediatric Society, 36(3), 250–255. https://doi.org/10.3126/jnps.v36i3.15539

Issue

Vol. 36 No. 3 (2016)

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).